Atsena Reports LIGHTHOUSE data at ARVO - Top-Institutions - MDSpire

Atsena Reports LIGHTHOUSE data at ARVO

Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a phase 1/2 clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS). The data were presented at the 2025 Association for Research in Vision and Ophthalmology meeting in Salt Lake City, Utah.

  • May 1, 2025

  • 3 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retinal Gene Therapy
    • Inherited Retinal Diseases

  • #2

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retinal Diseases
    • Gene Therapy

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Gene Therapy
    • Inherited Retinal Disorders

  • #4

    University of Pennsylvania Scheie Eye Institute
    University of Pennsylvania Scheie Eye Institute

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Retinal Gene Therapy
    • Inherited Retinal Diseases

Original Source(s)

Atsena Reports LIGHTHOUSE data at ARVO

  • May 1, 2025

Related Content

Early Fluid Resolution Predicts Faricimab Durability

Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.

Faster, Reliable, Patient-centered: What’s Next for SPECTRALIS<sup>®</sup>

Upcoming SPECTRALIS Software Version brings new speed, workflow flexibility, and diagnostic depth to multimodal retinal imaging

  • December 9, 2025

  • 5 min
New Product Applications: Glasses Offer Vision Enhancement With a Virtual Assistant

Two doctors have developed a groundbreaking wearable vision aid using AI technology to help individuals with low vision navigate daily activities, offering features such as a multimedia AI-powered assistant and lightweight, intuitive design.